Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Depreciation and Depletion: 2018-2024

Historic Depreciation and Depletion for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $10.7 million.

  • Legend Biotech's Depreciation and Depletion fell 9.87% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year decrease of 11.49%. This contributed to the annual value of $10.7 million for FY2024, which is 0.04% down from last year.
  • As of FY2024, Legend Biotech's Depreciation and Depletion stood at $10.7 million, which was down 0.04% from $10.7 million recorded in FY2023.
  • Legend Biotech's Depreciation and Depletion's 5-year high stood at $10.7 million during FY2023, with a 5-year trough of $6.2 million in FY2020.
  • Over the past 3 years, Legend Biotech's median Depreciation and Depletion value was $10.7 million (recorded in 2024), while the average stood at $10.5 million.
  • In the last 5 years, Legend Biotech's Depreciation and Depletion surged by 97.09% in 2020 and then decreased by 0.04% in 2024.
  • Yearly analysis of 5 years shows Legend Biotech's Depreciation and Depletion stood at $6.2 million in 2020, then soared by 30.56% to $8.1 million in 2021, then climbed by 24.99% to $10.2 million in 2022, then increased by 5.22% to $10.7 million in 2023, then dropped by 0.04% to $10.7 million in 2024.